Skip to content

Vvmed

Active
Private limited companyfounded 20196 yrs activeChemin du Tarbois 45, 4052 Chaudfontaine, BelgiumKBO/BCE: BE 0737.385.981
Summary

Vvmed has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €143,671 and a net result of €189,171. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 25% of 695 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).

Risk analysisWatch ReportCompare
VvmedActiveChecked score 94/100
Risk analysis ReportCompare

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
€651,222total assets 2025
Equity
€143,671
Profit
€189,171
Financial health
94 Excellent Checked score 2025
Bankruptcy chance 12 m
< 0.1%
Structure
Accounts 1 d early0 of 1 deed read
Why 94+ Sector Human health activities (NACE 86)+ Size: total assets €651,222+ Liquidity: current ratio 1.21, cash €468,378+ Figures for FY 2025 (filed 30-01-2026)Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Better than 52% of its sector peers (NACE 86, micro)
Performance against the sector, not lower risk
Every signal that weighs is under Signals.
Financial strength · tick = 2024
Strong
Solvency 47+21
equity 22.1% of total assets
Liquidity 58+8
short-term debt 76.7% · cash 71.9%
Profitability 95+19
return on assets 29.0%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (23,628 companies)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● 0.0% vs 11-2024 01-2025: < 0.1%▲ +7.0% vs 12-2024highest value 02-2025: < 0.1%▼ -21.7% vs 01-2025 03-2025: < 0.1%● 0.0% vs 02-2025 04-2025: < 0.1%● 0.0% vs 03-2025 05-2025: < 0.1%● 0.0% vs 04-2025 06-2025: < 0.1%▲ +2.8% vs 05-2025 07-2025: < 0.1%▼ -5.4% vs 06-2025 08-2025: < 0.1%● 0.0% vs 07-2025 09-2025: < 0.1%▲ +5.7% vs 08-2025 10-2025: < 0.1%● 0.0% vs 09-2025 11-2025: < 0.1%▲ +2.7% vs 10-2025 12-2025: < 0.1%● 0.0% vs 11-2025 01-2026: < 0.1%▲ +10.5% vs 12-2025 02-2026: < 0.1%▼ -35.7% vs 01-2026 03-2026: < 0.1%▼ -3.7% vs 02-2026 04-2026: < 0.1%● 0.0% vs 03-2026 05-2026: < 0.1%● 0.0% vs 04-2026 06-2026: < 0.1%● 0.0% vs 05-2026 07-2026: < 0.1%▼ -3.8% vs 06-2026lowest value 08-2026: < 0.1%● 0.0% vs 07-2026lowest value 09-2026: < 0.1%▲ +8.0% vs 08-2026 10-2026: < 0.1%▲ +3.7% vs 09-2026
  • Sector Human health activities (NACE 86) lowers the probability
  • Size: total assets €651,222 lowers the probability for this profile
  • Liquidity: current ratio 1.21, cash €468,378 lowers the probability
  • Figures for FY 2025 (filed 30-01-2026) lowers the probability
Credit up to €13,000 at 30 days acceptable
Liquidity tight (current ratio 1.21 against 0.89 in 2024; short-term debt: 76.7% and cash: 71.9% of total assets), and 77.9% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 86, micro). Better than this share of them on solvency 21%, liquidity 35%, profitability 55%, growth against the median 99%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 02-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Sector Human health activities (NACE 86)
In the bankruptcy model this factor lowers the probability.
KBO
lowers risk · Size: total assets €651,222
In the bankruptcy model this factor lowers the probability for this profile.
NBB · annual accounts
lowers risk · Liquidity: current ratio 1.21, cash €468,378
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
lowers risk · Figures for FY 2025 (filed 30-01-2026)
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
202122232425
2020 to 2025 · latest year €143,671
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 30-01-2026, 1 day ahead of the deadline.
NBB · 6 filings
Deviation from the deadline
2025
1 d early
2024
29 d early
2023
8 d early
2022
46 d early
2021
46 d early
2020
44 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 29 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today. Usually files around 2 January (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
30-06-2026 close03-10-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · full…
  2. Highest result since 2020net €189,171 ▲102%
  3. Equity above €100,000Eq €143,671 ▲3,093%

Key points

  • Positive: Result rose in 2025from €93,624 to €189,171 ▲ 102% View
  • Positive: Always filed on timeaccounts within the deadline every year 6 years View
  • Positive: 6 profitable years in a rowprofit 2025: €189,171 6 years View

By topic

Financials

Fiscal year
2025
Total assets
€651,222
Profit
€189,171
Solvency
22.1%
Total assets▲ 36.6%
Net result
20202025
Go to Financials

Timeline

Events
12
Since
2020
Next accounts
by 31-01-2027
  1. 30-01-2026Annual accounts filed
  2. 30-06-2025Highest result since 2020
  3. 30-06-2025Equity above €100,000
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
04-11-2019
Year ends
30-06
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure